Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

752
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
752
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

924
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
924
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

194
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
194
SN1 Reaction: Stereochemistry02:15

SN1 Reaction: Stereochemistry

10.2K
This lesson provides an in-depth discussion of the stereochemical outcomes in an SN1 reaction.
In the first step of an SN1 reaction, the bond between the electrophilic carbon and the leaving group ionizes to generate the carbocation intermediate. The second step of the mechanism is the nucleophilic attack.
In the formed carbocation, the positively charged carbon is sp2 hybridized with a trigonal planar geometry. As all the three substituents lie on the same plane, a plane of symmetry for the...
10.2K
SN1 Reaction: Kinetics02:05

SN1 Reaction: Kinetics

9.5K
In an SN2 reaction, the reaction rate depends on both the type of nucleophile and the substrate. A hindered tertiary alkyl halide is practically inert to the SN2 mechanism despite using a strong nucleophile.
However, Sir Christopher Ingold and Edward D. Hughes, who studied the kinetics of various nucleophilic substitution reactions, noticed that a tertiary alkyl halide does undergo a nucleophilic substitution reaction in the presence of a weak nucleophile. While studying the substitution...
9.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lp(a): A potentially modifiable cardiovascular risk factor.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2026
Same author

Implementation of a novel process for post-discharge microbiology results review for musculoskeletal infections in a large-volume academic healthcare system.

Journal of bone and joint infection·2025
Same author

Assessing pharmacists' knowledge and practices involving dietary supplement omega-3 fatty acids.

Journal of clinical lipidology·2025
Same author

Drug Interactions With Excessive Daytime Sleepiness Treatments.

The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians·2025
Same author

A narrative review of drugs targeting inflammation in vascular disease.

Postgraduate medicine·2025
Same author

Impact of pharmacist-led microbiology result follow-up post-discharge for patients undergoing inpatient infectious diseases consultation.

Antimicrobial stewardship & healthcare epidemiology : ASHE·2024

Related Experiment Video

Updated: Jan 22, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
12:17

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

Published on: May 21, 2017

11.8K

Alpha-1 Antitrypsin Replacement in Patients With COPD.

Adam D Wells, Anna Woods, Daniel E Hilleman

    P & T : a Peer-Reviewed Journal for Formulary Management
    |July 2, 2019
    PubMed
    Summary

    Genetic factors like Alpha-1 antitrypsin deficiency (AATD) significantly increase the risk of chronic obstructive pulmonary disease (COPD). Screening all COPD and adult-onset asthma patients for AATD is recommended.

    Keywords:
    alpha-1 antitrypsin deficiencychronic obstructive pulmonary disease

    More Related Videos

    Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
    08:50

    Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

    Published on: March 26, 2018

    12.2K
    Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
    09:44

    Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

    Published on: June 2, 2019

    22.5K

    Related Experiment Videos

    Last Updated: Jan 22, 2026

    Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
    12:17

    Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots

    Published on: May 21, 2017

    11.8K
    Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
    08:50

    Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement

    Published on: March 26, 2018

    12.2K
    Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo
    09:44

    Generation of Alpha-Synuclein Preformed Fibrils from Monomers and Use In Vivo

    Published on: June 2, 2019

    22.5K

    Area of Science:

    • Pulmonology
    • Genetics
    • Internal Medicine

    Background:

    • Chronic obstructive pulmonary disease (COPD) has multifactorial causes, including genetic predispositions.
    • Alpha-1 antitrypsin deficiency (AATD) is a significant genetic risk factor linked to COPD development and accelerated progression.

    Purpose of the Study:

    • To highlight the importance of genetic factors in COPD.
    • To emphasize the role of Alpha-1 antitrypsin deficiency (AATD) in COPD pathogenesis.
    • To advocate for widespread screening of AATD in at-risk populations.

    Main Methods:

    • Review of existing literature on COPD genetics.
    • Analysis of the association between AATD and COPD.
    • Evaluation of screening strategies for AATD.

    Main Results:

    • Genetic conditions, particularly AATD, are crucial contributors to COPD.
    • AATD is a well-established risk factor for both the onset and worsening of COPD.
    • Early identification of AATD can potentially alter disease management.

    Conclusions:

    • Genetic screening for AATD is essential for comprehensive COPD care.
    • Aggressive screening protocols for AATD should be implemented in patients diagnosed with COPD or adult-onset asthma.
    • Identifying AATD allows for targeted interventions and management strategies to mitigate COPD progression.